Zhou, X.; Zhao, J.; Zhang, J.V.; Wu, Y.; Wang, L.; Chen, X.; Ji, D.; Zhou, G.G.
Enhancing Therapeutic Efficacy of Oncolytic Herpes Simplex Virus with MEK Inhibitor Trametinib in Some BRAF or KRAS-Mutated Colorectal or Lung Carcinoma Models. Viruses 2021, 13, 1758.
https://doi.org/10.3390/v13091758
AMA Style
Zhou X, Zhao J, Zhang JV, Wu Y, Wang L, Chen X, Ji D, Zhou GG.
Enhancing Therapeutic Efficacy of Oncolytic Herpes Simplex Virus with MEK Inhibitor Trametinib in Some BRAF or KRAS-Mutated Colorectal or Lung Carcinoma Models. Viruses. 2021; 13(9):1758.
https://doi.org/10.3390/v13091758
Chicago/Turabian Style
Zhou, XuSha, Jing Zhao, Jian V. Zhang, Yinglin Wu, Lei Wang, Xiaoqing Chen, Dongmei Ji, and Grace Guoying Zhou.
2021. "Enhancing Therapeutic Efficacy of Oncolytic Herpes Simplex Virus with MEK Inhibitor Trametinib in Some BRAF or KRAS-Mutated Colorectal or Lung Carcinoma Models" Viruses 13, no. 9: 1758.
https://doi.org/10.3390/v13091758
APA Style
Zhou, X., Zhao, J., Zhang, J. V., Wu, Y., Wang, L., Chen, X., Ji, D., & Zhou, G. G.
(2021). Enhancing Therapeutic Efficacy of Oncolytic Herpes Simplex Virus with MEK Inhibitor Trametinib in Some BRAF or KRAS-Mutated Colorectal or Lung Carcinoma Models. Viruses, 13(9), 1758.
https://doi.org/10.3390/v13091758
